Many modern treatment options for type 2 diabetes, such as glucagon-like peptide-1 (GLP-1) receptor agonists, take a holistic approach, with substantial reductions in glycated hemoglobin (HbA1c) accompanied by benefits in blood pressure, serum lipid levels and body weight, and low risk of hypoglycemia [1]
The medication's effects on the hypothalamusthe brain's appetite control centerbecome more pronounced as dosing increases toward the 2.4 mg weekly target
Release and activity of histone in diseases
Unlike many therapeutic peptides, BPC-157 exhibits remarkable stability in acidic environments
Etanercept for therapy-resistant macrophage activation syndrome
At Parexel, one way we control acceleration in fast-enrolling trials is to select 5-10 sites for rapid and focused trial start-up while more gradually ramping up the remaining sites in increments of 5-10